@misc{indiciae549e1dae7c6b,
  title = {Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.},
  author = {Giuseppe Plazzi and Ronald R Grunstein and Emmanuel Mignot and Gert Jan Lammers and David T Plante and Erik Buntinx and Rafael Del R\&\#xed;o Villegas and Hailu Chen and Alexandra Lovett and Michael J Doane and Craig Hopkinson and Bhaskar Rege and Julie Himes and Yves Dauvilliers},
  year = {2026},
  doi = {10.1016/s1474-4422(26)00278-4},
  url = {https://pubmed.ncbi.nlm.nih.gov/42636845/},
  note = {Source identifier: 42636845}
}